Phase Ib Study of Rocbrutinib in Combination With R-CHOP in Patients With Newly Diagnosed B-cell Non-Hodgkin Lymphoma
Clinical trial NCT06251180 · RECRUITING
Trial details
- NCT number
- NCT06251180
- Sponsor
- Guangzhou Lupeng Pharmaceutical Company LTD.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-10
- Primary completion
- 2025-12-31
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.